Multiple sclerosis
A serial study using MRI in relapsing patients
Abstract
Prospective monthly magnetic resonance imaging (MRI) studies were done over 6 months in seven relapsing MS patients. MRI and neurologic evaluations were compared for sensitivity in detecting disease activity. Four patients were clinically stable throughout the study. Three patients had five clinical relapses, two localized to the spinal cord and three to the brainstem. Eighteen new and ten enlarging MRI lesions were seen in five patients. Most lesions were less than 10 mm in diameter. All were clinically silent. Two patients developed major enlarging MRI lesions (seen in three slices) which increased in size over 2 months and then gradually became smaller over 2 months, leaving behind small residual areas of abnormality. There were 36 follow-up scans, 17 of which (47%) showed evidence for increasing activity. Thirteen (36%) of the scans had new lesions, most of them being small. This study shows that MRI evidence for disease activity in MS is much more frequent than is clinical evidence.
Get full access to this article
View all available purchase options and get full access to this article.
Information & Authors
Information
Published In
Copyright
© 1988 by Edgell Communications, Inc.
Publication History
Published online: October 1, 1988
Published in print: October 1988
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases, Neuroimaging Clinics of North America, 34, 3, (317-334), (2024).https://doi.org/10.1016/j.nic.2024.03.002
- 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis, The Lancet Neurology, 20, 8, (653-670), (2021).https://doi.org/10.1016/S1474-4422(21)00095-8
- Concepts of Immune Therapy and Disease Management, Neuroimmunology, (59-71), (2021).https://doi.org/10.1007/978-3-030-61883-4_5
- Comment je fais une IRM pour le suivi des patients avec une sclérose en plaques ?, Journal d'imagerie diagnostique et interventionnelle, 3, 6, (384-388), (2020).https://doi.org/10.1016/j.jidi.2020.06.005
- DNA Methylation in Neuronal Development and Disease, The DNA, RNA, and Histone Methylomes, (103-140), (2019).https://doi.org/10.1007/978-3-030-14792-1_5
- Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease, American Journal of Roentgenology, 211, 5, (1099-1105), (2018).https://doi.org/10.2214/AJR.17.19155
- Multiple Sclerosis, International Encyclopedia of Public Health, (69-106), (2017).https://doi.org/10.1016/B978-0-323-99967-0.00343-4
- Multiple Sclerosis, International Encyclopedia of Public Health, (145-179), (2017).https://doi.org/10.1016/B978-0-12-803678-5.00295-2
- Imaging as an Outcome Measure in Multiple Sclerosis, Neurotherapeutics, 14, 1, (24-34), (2017).https://doi.org/10.1007/s13311-016-0479-6
- Correlazioni clinico radiologiche nella sclerosi multipla, Rivista di Neuroradiologia, 6, 1_suppl, (45-49), (2016).https://doi.org/10.1177/19714009930060S108
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.